Clinical management of BC relies on well-established prognostic and predictive parameters such as tumor grade, tumor size, lymph node involvement, expression of estrogen and progesterone receptors (ER, PR) as well as human epidermal growth factor (HER2) status [3]. This evidence concerns the gene ERBB2 and neoplasm.